share_log

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2024

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2024

essilorLuxottica:截至2024年4月30日的未償股本和投票權的披露
GlobeNewswire ·  05/27 12:00

Disclosure of Share Capital and Voting Rights Outstanding
as of April 30, 2024

股本和表決權未行使披露報告
截至2024年4月30日

(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)

(根據法國商業法第L.233-8 II條和Autorite ​​des Marches Financiers的221-1和223-16條款)

Charenton-le-Pont, France (May 27, 2024 - 6:00 pm) – As of April 30, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.

法國沙朗東讓,2024年5月27日下午6點 - 截至2024年4月30日,全球眼鏡鏡片,鏡架和太陽鏡設計,製造和銷售的全球領先者EssilorLuxottica的已發行股份和表決權如下所示。

April 30, 2024
Shares outstanding 453,861,047
Number of real voting rights (excluding treasury shares) 452,101,544
Theoretical number of voting rights (including treasury shares) 453,861,047
2024年4月30日
股份總數 453,861,047
實際表決權數量(不包括庫藏股) 452,101,544
理論表決權數量(包括庫藏股) 453,861,047

It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica's by-laws1.

請注意,根據EssilorLuxottica的章程第23條中的公式,任何股東的表決權上限爲31%。1.

For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website .

欲了解更多信息,請查閱2018年9月28日獲得AMF Visa編號18-460的招股說明書及其於2018年10月23日獲得AMF Visa編號18-494的證券說明書,均可在該網站上找到。

1EssilorLuxottica's by-laws are available on the Company's website under the section Governance / Publications.

1EEssilorLuxottica的章程可在公司網站的治理/出版物欄目下找到。

Attachment

附件

  • DOWNLOAD THE PRESS RELEASE
  • 下載新聞稿

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論